Intravitreal anti-VEGF injection treatment
intravitreal anti-vascular endothelial growth factor (VEGF) treatment
tests per year, UK, repeated injections (regimen not stated)
“Offer intravitreal anti-vascular endothelial growth factor (VEGF) treatment for late AMD (wet active) for eyes with visual acuity within the range specified in recommendation 1.5.6.”
NICE NG82, Age-related macular degeneration, recommendations, 2018-01
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Aflibercept, bevacizumab or ranibizumab, given as a course of eye injections.
Used in
Kept as evidence; no figure on the platform is computed from it yet.